A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.
about
Everolimus-eluting stents in interventional cardiologyNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-AnalysisEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesFirst-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patientsAdvances in stent technologies and their effect on clinical efficacy and safetyUpdate on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarPaclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International study.In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study.One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: the e-BioMatrix multicenter post marketing surveillance registry in India.Everolimus-eluting stents: update on current clinical studies.Drug-eluting coronary stents - focus on improved patient outcomes.A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native CoroControversies in the use & implementation of drug-eluting stent technology.The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view.Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).Coronary stents and vascular response to implantation: literature review.Drug-eluting stents in multivessel coronary artery disease: cost effectiveness and clinical outcomes.Are all stents equal - Need for scoring system to evaluate stents?Undesired Outcomes of the Catania Stent Compared to the Xience Stent in Patients Undergoing Angioplasty: A Double-Blind Randomized Controlled Trial.A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry - XIENCE V performance evaluation (THRIVE study).
P2860
Q24630321-B48B9B78-CC2E-4961-8B47-51B0A4B04C4AQ24642679-32BC0F70-FB88-4074-BD0C-3A0F9A5BD9B5Q26750693-86F88C90-2F52-47D1-88B3-5DE8B38753D8Q26798582-AB204312-B63D-4447-A1AD-F870046553C7Q28543594-C1592650-A31C-4658-92B1-950FA5CEF76CQ28972437-9EA224AA-D73C-4008-83B2-6A017EDB84B6Q33571243-F87AF4AA-3406-4853-AC37-961011DE9694Q34354151-897B6B8F-9BD7-41AA-9CA7-8B6383A57E4FQ34432576-BBD14E86-A111-414B-83B2-EA0A7816266DQ34548825-C51BC578-830F-42AC-9128-20AC17212822Q35793491-3B03126C-713D-43C7-81CD-20698AC69F36Q36154232-640B74E9-E6DA-4942-9FD7-2194E9ED298FQ36954581-0C0A37F0-6554-47FC-988E-7EEB5601BE01Q36995923-63947A52-CD04-48BD-8C6B-E9DE054A3354Q37284036-499E2CDD-F9B2-462B-AD04-28E93F51E8DEQ37329589-65010408-C587-4B2B-B9AB-72E135038C94Q37387136-D0B1F5FA-7748-4388-AC9E-D2541AC91B26Q38037072-39D8D325-5A0B-489C-B556-CABB82B67F23Q38037077-E319D26A-CF20-43CE-A14A-8E5B889BCF2AQ38067519-3CCA6EB3-7423-43C9-8CF1-612936036744Q38079934-ACFA1209-6D70-46E2-BE0B-715B07655B0BQ38310049-40357559-8BCA-4DF0-9E4E-3DEE9962DF52Q38372442-63E46D08-801B-4831-831A-A643E193F314Q41057555-8EED7DCB-FF84-454C-8367-24065BD1801EQ41889254-28262298-FBDB-4D62-99E3-D3F7EAF3C036Q42380197-687DDFFB-18F6-4F79-8902-223F552276C4Q47133703-CF9AFAC6-11DD-4ED3-8EAA-B3C2FEAF2BCBQ50685296-744D451F-CB55-446C-8F85-22A7081ABC07
P2860
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@en
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@nl
type
label
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@en
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@nl
prefLabel
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@en
A randomised comparison of an ...... ary stent:the SPIRIT II trial.
@nl
P2093
P1476
A randomised comparison of an ...... nary stent:the SPIRIT II trial
@en
P2093
Ashok Seth
Gert Richardt
Jan J Piek
Joachim J Schofer
Joost Daemen
Jörg Neuzner
Karine Miquel-Herbert
Leif Thuesen
Marcus Wiemer
P304
P577
2006-11-01T00:00:00Z